§ 13F · FUND PROFILE
Avoro Capital Advisors LLC.
Institutional filer · behavioral pattern: Other. Summary pending.
AUM · — (13F)Positions · 34Turnover · — · Q4Filed · Feb 17, 2026
CONCENTRATION
—
Top 10 holdings
NEW BUYS
0
+$10174.4T deployed
EXITS
0
No exits
SECTOR SHIFT
—
No prior quarter data
3YR HIT RATE
—
Top-5 overlap
§ 01 · TOP HOLDINGS
The book · Q4 2025
FILED FEB 17, 2026
| # | Ticker | Name | Shares | $ value | % port | Δ Q4 |
|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | 2.61M | $1269.8T | 12.5% | NEW |
| 2 | ASND | ASCENDIS PHARMA | 5.11M | $1089.9T | 10.7% | NEW |
| 3 | MDGL | MADRIGAL PHARMACEUTICALS INC | 1.81M | $1052.6T | 10.3% | NEW |
| 4 | ARGX | ARGENX SE | 990K | $832.5T | 8.2% | NEW |
| 5 | KRYS | KRYSTAL BIOTECH INC | 2.89M | $712.2T | 7.0% | NEW |
| 6 | ARWR | ARROWHEAD PHARMACEUTICALS INC | 10.63M | $705.4T | 6.9% | NEW |
| 7 | KYMR | KYMERA THERAPEUTICS INC | 7.47M | $581.6T | 5.7% | NEW |
| 8 | GPCR | STRUCTURE THERAPEUTICS INC | 6.56M | $455.9T | 4.5% | NEW |
| 9 | RNAGBP | AVIDITY BIOSCIENCES INC | 5.46M | $393.5T | 3.9% | NEW |
| 10 | CNTA | CENTESSA PHARMACEUTICALS PLC | 14.56M | $364.0T | 3.6% | NEW |
§ 02 · SECTOR ALLOCATION
Where the money is
Sector data pending
§ 03 · THE AVORO SIGNAL
AC read
Avoro Capital Advisors LLC is classified as a Other fund.
Read the full dossier →§ 04 · FILING HISTORY
Q-by-Q deltas
1 FILINGS
Q4 2025
Steady book
+0 buys · −0 exits · 0 changed